Stocks
baxalta IncorporatedBXLT
YHDHealthcareBiotechnology
A biopharmaceutical developer focused on therapies for hemophilia, immune disorders, and other rare diseases, created through the 2015 spin-off of Baxter International’s biopharma unit. The company marketed plasma-derived and recombinant treatments while advancing a pipeline targeting hematology and...
Congressional Interest in baxalta Incorporated (BXLT)
6 members of Congress have disclosed 12 trades in baxalta Incorporated (BXLT), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 8 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
12
Unique Politicians
6
Buys
2
Sells
8
Who in Congress Is Trading BXLT?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2016-06-03 | Richard L. Hanna | sell | $100K – $250K |
| 2016-04-12 | JAMES B. RENACCI | sell | $15K – $50K |